X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
IFCI: Deteriorating health - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • May 18, 2001

    IFCI: Deteriorating health

    IFCI, had reported a drop of 43% in its nine months earnings of FY01. Its financial health has taken a turn for the worse with rising non performing assets. On a revenue base of over Rs 21 bn, net margins of just 1.8% are very discouraging.

    IFCI's operating margins continue to slide from over 24% in FY98 to just 10% now. This is largely due to high cost of funds and low growth in advances. The institution's sanctions and disbursements for the period April '00-Jan '01 fell by 38% and 42% respectively. On the other hand during the same period, sanctions and disbursements of the industry grew by over 10%.

    (Rs m) 9mth FY00 9mth FY01 Change
    Income from Operations 21,795 21,207 -2.7%
    Other Income 151 44 -70.8%
    Interest & Depreciation 19,069 19,023 -0.2%
    Operating Profit (EBDIT) 2,726 2,184 -19.9%
    Operating Profit Margin (%) 12.5% 10.3%  
    Other Expenses 724 377 -48.0%
    Depreciation 538 457 -15.1%
    Profit before Tax 1,614 1,395 -13.6%
    Provisions and write offs 949 1,013 6.8%
    Tax - -  
    Profit after Tax/(Loss) 665 382 -42.6%
    Net profit margin (%) 3.1% 1.8%  
    Number of shares (eoy) 353 640  
    Diluted Earnings per share* 1.4 0.8  
    *(annualised)      
    P/E (at current price)   6.3  

    The level of NPAs at 21% of advances is the highest in IFCI compared to its peers in the industry. The major reason of climbing bad loans is the higher proportion of lending to co-operatives (20% of total loans). Till FY95, these co-operatives did not pay any interest but only principal. Also, it has high concentration in industries such as textile and sugar. Project finance to basic commodity sectors has marred the performance of the institution since the last few years. Steel and textiles sectors had experienced massive cost overruns and commodity prices were severely affected by international factors. IFCI failed to increase the proportion of non-project financing which is considered non-risky, although the margins are also low.

    IFCI has recently appointed an expert committee to restructure its financial health and to resolve the problems of bad loans. The committee has projected a nearly ten fold increase in the financial institution's net profits to Rs 5.3 bn by the end of FY07 (from Rs 0.6 bn in FY00). The projections of the committee are however based on the assumptions that the government would lend to the institution an amount of Rs 4 bn to shore up its weak capital adequacy ratio (8.8% in FY00).

    However, whether the projections of the committee would be met depends on IFCI's success in dealing with large amount of NPAs, raising low cost of funds and generating newer income streams. Looking at the current scenario it is likely to take over 3 years for the institution to strengthen its financial health.

    At the current market price of Rs 5 IFCI is trading at a P/E of 6 times its 9 months annualised earnings. Its price to book value ratio of 0.2 times suggests the deteriorating health of the institution.

     

     

    Equitymaster requests your view! Post a comment on "IFCI: Deteriorating health". Click here!

      
     

    More Views on News

    HDFC: Red Flag in Developer Loans (Quarterly Results Update - Detailed)

    Aug 10, 2017

    HDFC starts FY18 on robust loan growth but asset quality slips on increased exposure to developer loans.

    Shriram Trans Fin: FY17 Ends on a Tepid Note due to Regulatory Headwinds (Quarterly Results Update - Detailed)

    Jun 22, 2017

    Demonetisation led slowdown coupled with shift to stringent bad loan norms keep Shriram Transport Finance on a slow wicket.

    Power Finance Corp: Alignment with RBI Norms Knocks Down FY17 Earnings (Quarterly Results Update - Detailed)

    Jun 14, 2017

    Power Finance Corporation earnings hit by RBI mandated higher provision on state government power generation projects where the recovery continues to be 100%.

    IDFC: Ends FY17 on a Healthy Note (Quarterly Results Update - Detailed)

    May 30, 2017

    IDFC regains its tempo in FY17 post the demerger of the banking business.

    HDFC: Conservative Provisioning tempers down FY17 earnings (Quarterly Results Update - Detailed)

    May 9, 2017

    HDFC ends FY17 on a tepid note as it remains conservative on the asset quality front.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

    Aug 10, 2017

    Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    IFCI SHARE PRICE


    Aug 18, 2017 (Close)

    TRACK IFCI

    IFCI - SHRIRAM TRANSPORT FIN. COMPARISON

    Compare Company With Charts

    COMPARE IFCI WITH

    MARKET STATS